
    
      The objective of this study is to evaluate the therapeutic effectiveness and cost-effectivity
      of pharmaceutical care for asthma patients. Patients will be randomly allocated to the
      control group (= no input from pharmacist) or intervention group (= with pharmaceutical care
      at baseline and follow-up visits over 6 months).
    
  